LIF and non-small cell lung carcinoma: Overall, LIF plays an important pathophysiological role in cancer and cardiovascular diseases, and may be considered as a new inflammatory biomarker to monitor the status of tumor progression and underlying cardiovascular damage in NSCLC patients.